Pfizer Notches A Quarterly Win On Covid. But Is It Sustainable? - Investor's Business Daily
2 months ago
Pfizer Notches A Quarterly Win On Covid. But Is It Sustainable? Investor's Business DailyPfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off CNBCPfizer beats Q4, FY '24 earnings estimates, stock flat in early trading Yahoo FinancePfizer Eyes Deals up to $15B, With ‘Fruitful’ China Discussions Ongoing BioSpacePfizer Earnings: After Solid Results, Reaffirmed 2025 Guidance Morningstar
Click here to Read more